AAAAAA

   
Results: 1-19 |
Results: 19
TUMOR SELECTIVE ACTIVATION OF A DOXORUBICIN PRODRUG (DOX-GA3) IN HUMAN OVARIAN-CANCER XENOGRAFTS
Authors: HOUBA PHJ BOVEN E LEENDERS RGG VANDERMEULENMULLEMAN IH SCHEEREN JW PINEDO HM HAISMA HJ
Citation: Phj. Houba et al., TUMOR SELECTIVE ACTIVATION OF A DOXORUBICIN PRODRUG (DOX-GA3) IN HUMAN OVARIAN-CANCER XENOGRAFTS, Annals of oncology, 9, 1998, pp. 194-194
CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN OF SINGLE-CHAINANTI-CARCINOMA ANTIBODY 323 A3 AND HUMAN BETA-GLUCURONIDASE/
Authors: HAISMA HJ BRAKENHOFF RH VANDERMEULENMUILEMAN I PINEDO HM BOVEN E
Citation: Hj. Haisma et al., CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN OF SINGLE-CHAINANTI-CARCINOMA ANTIBODY 323 A3 AND HUMAN BETA-GLUCURONIDASE/, Cancer immunology and immunotherapy, 45(5), 1998, pp. 266-272
CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN OF SINGLE-CHAINANTI-CD20 ANTIBODY AND HUMAN BETA-GLUCURONIDASE FOR ANTIBODY-DIRECTEDENZYME PRODRUG THERAPY
Authors: HAISMA HJ SERNEE MF HOOIJBERG E BRAKENHOFF RH VANDENMEULENMULLEMAN IH PINEDO HM BOVEN E
Citation: Hj. Haisma et al., CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN OF SINGLE-CHAINANTI-CD20 ANTIBODY AND HUMAN BETA-GLUCURONIDASE FOR ANTIBODY-DIRECTEDENZYME PRODRUG THERAPY, Blood, 92(1), 1998, pp. 184-190
DAUNORUBICIN-GA3, A NOVEL PRODRUG FOR USE IN GENE-THERAPY
Authors: HAISMA HJ PINEDO HM VANDEMEULENMUILEMAN IH HOUBA PHJ LEENDERS RGG SCHEEREN JW BOVEN E
Citation: Hj. Haisma et al., DAUNORUBICIN-GA3, A NOVEL PRODRUG FOR USE IN GENE-THERAPY, Cancer gene therapy, 4(5), 1997, pp. 307-307
IMMUNOLIPOSOMES BEARING ENZYMES (IMMUNO-ENZYMOSOMES) FOR SITE-SPECIFIC ACTIVATION OF ANTICANCER PRODRUGS
Authors: STORM G VINGERHOEDS MH CROMMELIN DJA HAISMA HJ
Citation: G. Storm et al., IMMUNOLIPOSOMES BEARING ENZYMES (IMMUNO-ENZYMOSOMES) FOR SITE-SPECIFIC ACTIVATION OF ANTICANCER PRODRUGS, Advanced drug delivery reviews, 24(2-3), 1997, pp. 225-231
ZIRCONIUM-LABELED MONOCLONAL-ANTIBODIES AND THEIR DISTRIBUTION IN TUMOR-BEARING NUDE-MICE
Authors: MEIJS WE HAISMA HJ KLOK RP VANGOG FB KIEVIT E PINEDO HM HERSCHEID JDM
Citation: We. Meijs et al., ZIRCONIUM-LABELED MONOCLONAL-ANTIBODIES AND THEIR DISTRIBUTION IN TUMOR-BEARING NUDE-MICE, The Journal of nuclear medicine, 38(1), 1997, pp. 112-118
IMPROVED CHARACTERISTICS OF A HUMAN BETA-GLUCURONIDASE-ANTIBODY CONJUGATE AFTER DEGLYCOSYLATION FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUGTHERAPY
Authors: HOUBA PHJ BOVEN E HAISMA HJ
Citation: Phj. Houba et al., IMPROVED CHARACTERISTICS OF A HUMAN BETA-GLUCURONIDASE-ANTIBODY CONJUGATE AFTER DEGLYCOSYLATION FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUGTHERAPY, Bioconjugate chemistry, 7(5), 1996, pp. 606-611
A FACILE METHOD FOR THE LABELING OF PROTEINS WITH ZIRCONIUM ISOTOPES
Authors: MEIJS WE HAISMA HJ VANDERSCHORS R WIJBRANDTS R VANDENOEVER K KLOK RP PINEDO HM HERSCHEID JDM
Citation: We. Meijs et al., A FACILE METHOD FOR THE LABELING OF PROTEINS WITH ZIRCONIUM ISOTOPES, Nuclear medicine and biology, 23(4), 1996, pp. 439-448
IMMUNOLIPOSOMES AS ENZYME-CARRIERS (IMMUNO-ENZYMOSOMES) FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - OPTIMIZATION OF PRODRUG ACTIVATING CAPACITY
Authors: VINGERHOEDS MH HAISMA HJ BELLIOT SO SMIT RHP CROMMELIN DJA STORM G
Citation: Mh. Vingerhoeds et al., IMMUNOLIPOSOMES AS ENZYME-CARRIERS (IMMUNO-ENZYMOSOMES) FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - OPTIMIZATION OF PRODRUG ACTIVATING CAPACITY, Pharmaceutical research, 13(4), 1996, pp. 604-610
COMPARISON OF THE MONOCLONAL-ANTIBODIES 17-1A AND 323 A3 - THE INFLUENCE OF THE AFFINITY ON TUMOR UPTAKE AND EFFICACY OF RADIOIMMUNOTHERAPYIN HUMAN OVARIAN-CANCER XENOGRAFTS/
Authors: KIEVIT E PINEDO HM SCHLUPER HMM HAISMA HJ BOVEN E
Citation: E. Kievit et al., COMPARISON OF THE MONOCLONAL-ANTIBODIES 17-1A AND 323 A3 - THE INFLUENCE OF THE AFFINITY ON TUMOR UPTAKE AND EFFICACY OF RADIOIMMUNOTHERAPYIN HUMAN OVARIAN-CANCER XENOGRAFTS/, British Journal of Cancer, 73(4), 1996, pp. 457-464
CHARACTERIZATION OF NOVEL ANTHRACYCLINE PRODRUGS ACTIVATED BY HUMAN BETA-GLUCURONIDASE FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY
Authors: HOUBA PHJ LEENDERS RGG BOVEN E SCHEEREN JW PINEDO HM HAISMA HJ
Citation: Phj. Houba et al., CHARACTERIZATION OF NOVEL ANTHRACYCLINE PRODRUGS ACTIVATED BY HUMAN BETA-GLUCURONIDASE FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY, Biochemical pharmacology, 52(3), 1996, pp. 455-463
SYNTHESIS AND EVALUATION OF NOVEL DAUNOMYCIN-PHOSPHATE-BETA-GLUCURONIDE, DAUNOMYCIN-PHOSPHATE-BETA-GLUCOSIDE, DAUNOMYCIN-SULFATE-BETA-GLUCURONIDE AND DAUNOMYCIN-SULFATE-BETA-GLUCOSIDE PRODRUGS FOR APPLICATION IN ADEPT
Authors: LEENDERS RGG SCHEEREN HW HOUBA PHJ BOVEN E HAISMA HJ
Citation: Rgg. Leenders et al., SYNTHESIS AND EVALUATION OF NOVEL DAUNOMYCIN-PHOSPHATE-BETA-GLUCURONIDE, DAUNOMYCIN-PHOSPHATE-BETA-GLUCOSIDE, DAUNOMYCIN-SULFATE-BETA-GLUCURONIDE AND DAUNOMYCIN-SULFATE-BETA-GLUCOSIDE PRODRUGS FOR APPLICATION IN ADEPT, Bioorganic & medicinal chemistry letters, 5(24), 1995, pp. 2975-2980
MINOR HUMAN-ANTIBODY RESPONSE TO A MOUSE AND CHIMERIC MONOCLONAL-ANTIBODY AFTER A SINGLE IV INFUSION IN OVARIAN-CARCINOMA PATIENTS - A COMPARISON OF 5 ASSAYS
Authors: BUIST MR KENEMANS P VANKAMP GJ HAISMA HJ
Citation: Mr. Buist et al., MINOR HUMAN-ANTIBODY RESPONSE TO A MOUSE AND CHIMERIC MONOCLONAL-ANTIBODY AFTER A SINGLE IV INFUSION IN OVARIAN-CARCINOMA PATIENTS - A COMPARISON OF 5 ASSAYS, Cancer immunology and immunotherapy, 40(1), 1995, pp. 24-30
A MONOCLONAL-ANTIBODY AGAINST HUMAN BETA-GLUCURONIDASE FOR APPLICATION IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY
Authors: HAISMA HJ VANMUIJEN M SCHEFFER G SCHEPER RJ PINEDO HM BOVEN E
Citation: Hj. Haisma et al., A MONOCLONAL-ANTIBODY AGAINST HUMAN BETA-GLUCURONIDASE FOR APPLICATION IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY, Hybridoma, 14(4), 1995, pp. 377-382
MAB-105 ANTI-HUMAN BETA-GLUCURONIDASE
Authors: HAISMA HJ
Citation: Hj. Haisma, MAB-105 ANTI-HUMAN BETA-GLUCURONIDASE, Hybridoma, 14(4), 1995, pp. 402-402
BETA-GLUCURONYL CARBAMATE BASED PRO-MOIETIES DESIGNED FOR PRODRUGS INADEPT
Authors: LEENDERS RGG GERRITS KAA RUIJTENBEEK R SCHEEREN HW HAISMA HJ BOVEN E
Citation: Rgg. Leenders et al., BETA-GLUCURONYL CARBAMATE BASED PRO-MOIETIES DESIGNED FOR PRODRUGS INADEPT, Tetrahedron letters, 36(10), 1995, pp. 1701-1704
PRODUCTION OF HIGHLY PURE NO-CARRIER ADDED ZR-89 FOR THE LABELING OF ANTIBODIES WITH A POSITRON EMITTER
Authors: MEIJS WE HERSCHEID JDM HAISMA HJ WIJBRANDTS R VANLANGEVELDE F VANLEUFFEN PJ MOOY R PINEDO HM
Citation: We. Meijs et al., PRODUCTION OF HIGHLY PURE NO-CARRIER ADDED ZR-89 FOR THE LABELING OF ANTIBODIES WITH A POSITRON EMITTER, Applied radiation and isotopes, 45(12), 1994, pp. 1143-1147
COMPARISON OF NONINVASIVE APPROACHES TO RED MARROW DOSIMETRY FOR RADIOLABELED MONOCLONAL-ANTIBODIES
Authors: PLAIZIER MABD ROOS JC TEULE GJJ VANDIEREN EB DENHOLLANDER W HAISMA HJ DEJAGER RL VANLINGEN A
Citation: Mabd. Plaizier et al., COMPARISON OF NONINVASIVE APPROACHES TO RED MARROW DOSIMETRY FOR RADIOLABELED MONOCLONAL-ANTIBODIES, European journal of nuclear medicine, 21(3), 1994, pp. 216-222
A NEW APPLICATION FOR LIPOSOMES IN CANCER-THERAPY - IMMUNOLIPOSOMES BEARING ENZYMES (IMMUNO-ENZYMOSOMES) FOR SITE-SPECIFIC ACTIVATION OF PRODRUGS
Authors: VINGERHOEDS MH HAISMA HJ VANMUIJEN M VANDERIJT RBJ CROMMELIN DJA STORM G
Citation: Mh. Vingerhoeds et al., A NEW APPLICATION FOR LIPOSOMES IN CANCER-THERAPY - IMMUNOLIPOSOMES BEARING ENZYMES (IMMUNO-ENZYMOSOMES) FOR SITE-SPECIFIC ACTIVATION OF PRODRUGS, FEBS letters, 336(3), 1993, pp. 485-490
Risultati: 1-19 |